Skip to main content
. 2012 May 17;4(2):107–116. doi: 10.4055/cios.2012.4.2.107

Table 2.

Adjuvant Therapies for GCT

graphic file with name cios-4-107-i002.jpg

GCT: giant cell tumor, RANKL: receptor activator of nuclear factor kappa-B ligand, IFNα: interferon alpha, bFGF: basic fibroblast growth factor, VEGF: vascular endothelial growth factor.